Document is current
Any future updates will be listed below
-
Authors
,
de Haro, Candelaria http://orcid.org/0000-0002-2668-1030
Magrans, Rudys
López-Aguilar, Josefina
Montanyà, Jaume
Lena, Enrico
Subirà, Carles
Fernandez-Gonzalo, Sol
Gomà, Gemma
Fernández, Rafael
Albaiceta, Guillermo M.
Skrobik, Yoanna
Lucangelo, Umberto
Murias, Gastón
Ochagavia, Ana
Kacmarek, Robert M.
Rue, Montserrat
Blanch, Lluís
-
Funding
Funding for this research was provided by:
Instituto de Salud Carlos III (PI09/91074, PI13/02204 and PI16/01606)
FEDER (RTC-2017-6193-1)
MCYIN (Plan Avanza TSI-020302-2008-38)
- License Information
-
More Information
Article History
Received: 29 March 2019
Accepted: 26 June 2019
First Online: 5 July 2019
Ethics approval and consent to participate
: The institutional review boards of each participating ICU approved the protocol, waiving informed consent because the study was non-interventional, posed no added risk to patients, and did not interfere with usual care.
: Not applicable.
: Drs. Blanch and Murias are inventors of the Corporació Sanitaria Parc Taulí owned US patent: “Method and system for managing related patient parameters provided by a monitoring device,” US Patent No. <i>12/538,940.</i> Blanch, Montanya, Murias, and Lucangelo own stock options of BetterCare S.L., which is a research and development spinoff of Corporació Sanitària Parc Taulí (Spain). Kacmarek is a consultant for Medtronic and Orange Medical and has received research grants from Medtronic and VennerMedical. The other authors declare that they have no competing interests.
